BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Stephen ZR, Zhang M. Recent Progress in the Synergistic Combination of Nanoparticle-Mediated Hyperthermia and Immunotherapy for Treatment of Cancer. Adv Healthc Mater 2021;10:e2001415. [PMID: 33236511 DOI: 10.1002/adhm.202001415] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 8.5] [Reference Citation Analysis]
Number Citing Articles
1 Zhu Y, Li Q, Wang C, Hao Y, Yang N, Chen M, Ji J, Feng L, Liu Z. Rational Design of Biomaterials to Potentiate Cancer Thermal Therapy. Chem Rev 2023. [PMID: 36912061 DOI: 10.1021/acs.chemrev.2c00822] [Reference Citation Analysis]
2 Devendrapandi G, I Sahay M, Padmanaban D, Panneerselvam A, Palraj R, Thanikasalam R, kuppan S, Sadaiyandi V, Balu R, Rajendiran N. Biogenic Synthesis of Gold Nanoparticles using Bael Fruit Juice and its efficacy against human A-549 lung cancer cell line. Inorganic Chemistry Communications 2023. [DOI: 10.1016/j.inoche.2023.110636] [Reference Citation Analysis]
3 Varzandeh M, Sabouri L, Mansouri V, Gharibshahian M, Beheshtizadeh N, Hamblin MR, Rezaei N. Application of nano‐radiosensitizers in combination cancer therapy. Bioengineering & Transla Med 2023. [DOI: 10.1002/btm2.10498] [Reference Citation Analysis]
4 Wan L, Cao Y, Cheng C, Tang R, Wu N, Zhou Y, Xiong X, He H, Lin X, Jiang Q, Wang X, Guo X, Wang D, Ran H, Ren J, Zhou Y, Hu Z, Li P. Biomimetic, pH-Responsive Nanoplatforms for Cancer Multimodal Imaging and Photothermal Immunotherapy. ACS Appl Mater Interfaces 2023;15:1784-97. [PMID: 36580421 DOI: 10.1021/acsami.2c16667] [Reference Citation Analysis]
5 Xia Y, Yang R, Zhu J, Wang H, Li Y, Fan J, Fu C. Engineered nanomaterials trigger abscopal effect in immunotherapy of metastatic cancers. Front Bioeng Biotechnol 2022;10. [DOI: 10.3389/fbioe.2022.890257] [Reference Citation Analysis]
6 Zhao J, Zhang C, Wang W, Li C, Mu X, Hu K. Current progress of nanomedicine for prostate cancer diagnosis and treatment. Biomed Pharmacother 2022;155:113714. [PMID: 36150309 DOI: 10.1016/j.biopha.2022.113714] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Zhang K, Sun X, Sun W, Wang M, Han F. Exosomal microRNA-506 inhibits biological activity of lung adenocarcinoma cells and increases sensitivity to cisplatin-based hyperthermia. Cell Signal 2022;100:110469. [PMID: 36115547 DOI: 10.1016/j.cellsig.2022.110469] [Reference Citation Analysis]
8 Yang X, Gao M, Xu R, Tao Y, Luo W, Wang B, Zhong W, He L, He Y. Hyperthermia combined with immune checkpoint inhibitor therapy in the treatment of primary and metastatic tumors. Front Immunol 2022;13:969447. [DOI: 10.3389/fimmu.2022.969447] [Reference Citation Analysis]
9 Bruvera I, Actis D, Soto P, Blank V, Roguin L, van Raap MF, Zélis PM. Raiders of the lost SAR: Radiofrequency cycles of magnetic nanoflowers inside a tumor. Journal of Magnetism and Magnetic Materials 2022. [DOI: 10.1016/j.jmmm.2022.169869] [Reference Citation Analysis]
10 Lin X, Li F, Gu Q, Wang X, Zheng Y, Li J, Guan J, Yao C, Liu X. Gold-seaurchin based immunomodulator enabling photothermal intervention and αCD16 transfection to boost NK cell adoptive immunotherapy. Acta Biomater 2022;146:406-20. [PMID: 35470078 DOI: 10.1016/j.actbio.2022.04.029] [Reference Citation Analysis]
11 Han CL, Meng GX, Ding ZN, Dong ZR, Chen ZQ, Hong JG, Yan LJ, Liu H, Tian BW, Yang LS, Xue JS, Li T. The Predictive Potential of the Baseline C-Reactive Protein Levels for the Efficiency of Immune Checkpoint Inhibitors in Cancer Patients: A Systematic Review and Meta-Analysis. Front Immunol 2022;13:827788. [PMID: 35211122 DOI: 10.3389/fimmu.2022.827788] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Li X, Duan S, Zheng Y, Yang Y, Wang L, Li X, Zhang Q, Thorne RF, Li W, Yang D. Hyperthermia inhibits growth of nasopharyngeal carcinoma through degradation of c-Myc. International Journal of Hyperthermia 2022;39:358-71. [DOI: 10.1080/02656736.2022.2038282] [Reference Citation Analysis]
13 Gao Y, Wu Y. Recent advances of chitosan-based nanoparticles for biomedical and biotechnological applications. Int J Biol Macromol 2022;203:379-88. [PMID: 35104473 DOI: 10.1016/j.ijbiomac.2022.01.162] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 15.0] [Reference Citation Analysis]
14 Liu Y, Shang W, Liu H, Hui H, Wu J, Zhang W, Gao P, Guo K, Guo Y, Tian J. Biomimetic manganese-eumelanin nanocomposites for combined hyperthermia-immunotherapy against prostate cancer. J Nanobiotechnol 2022;20. [DOI: 10.1186/s12951-022-01248-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
15 Shevtsov M, Kaesler S, Posch C, Multhoff G, Biedermann T. Magnetic nanoparticles in theranostics of malignant melanoma. EJNMMI Res 2021;11:127. [PMID: 34905138 DOI: 10.1186/s13550-021-00868-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
16 Liu H, Yang XL, Yang XY, Dong ZR, Chen ZQ, Hong JG, Li T. The Prediction Potential of the Pretreatment Lung Immune Prognostic Index for the Therapeutic Outcomes of Immune Checkpoint Inhibitors in Patients With Solid Cancer: A Systematic Review and Meta-Analysis. Front Oncol 2021;11:691002. [PMID: 34631525 DOI: 10.3389/fonc.2021.691002] [Reference Citation Analysis]
17 Zhu M, Yang M, Zhang J, Yin Y, Fan X, Zhang Y, Qin S, Zhang H, Yu F. Immunogenic Cell Death Induction by Ionizing Radiation. Front Immunol 2021;12:705361. [PMID: 34489957 DOI: 10.3389/fimmu.2021.705361] [Cited by in Crossref: 27] [Cited by in F6Publishing: 33] [Article Influence: 13.5] [Reference Citation Analysis]
18 Oladipo AO, Lebepe TC, Ncapayi V, Tsolekile N, Parani S, Songca SP, Mori S, Kodama T, Oluwafemi OS. The Therapeutic Effect of Second Near-Infrared Absorbing Gold Nanorods on Metastatic Lymph Nodes via Lymphatic Delivery System. Pharmaceutics 2021;13:1359. [PMID: 34575435 DOI: 10.3390/pharmaceutics13091359] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
19 Chung S, Revia RA, Zhang M. Iron oxide nanoparticles for immune cell labeling and cancer immunotherapy. Nanoscale Horiz 2021;6:696-717. [PMID: 34286791 DOI: 10.1039/d1nh00179e] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
20 Liu X, Sun H, Wang X, Meng H. Immunological effects of nano-enabled hyperthermia for solid tumors: opportunity and challenge. Front Chem Sci Eng 2022;16:333-44. [DOI: 10.1007/s11705-021-2059-5] [Reference Citation Analysis]
21 Wang L, Yu Y, Wei D, Zhang L, Zhang X, Zhang G, Ding D, Xiao H, Zhang D. A Systematic Strategy of Combinational Blow for Overcoming Cascade Drug Resistance via NIR-Light-Triggered Hyperthermia. Adv Mater 2021;33:e2100599. [PMID: 33834553 DOI: 10.1002/adma.202100599] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 16.0] [Reference Citation Analysis]
22 Fu L, Zhou X, He C. Polymeric Nanosystems for Immunogenic Cell Death-Based Cancer Immunotherapy. Macromol Biosci 2021;21:e2100075. [PMID: 33885225 DOI: 10.1002/mabi.202100075] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]